GRPR and posterior cortical atrophy: In order to further improve the efficiency and efficacy of the existing PSMA radioligands for PCa diagnosis and radionuclide therapy several structural modifications have been suggested for reducing their uptake in off-target tissues or utilizing multitargeting (i.e., albumin, GRPr and integrin αvβ3).